Scientific Opinion related to a notification from the International Organisation of Vine and Wine (OIV) on casein/caseinate/milk products to be used in the manufacture of wine as clarification processing aids pursuant to Article 6, paragraph 11 of Directive 2000/13/EC – for permanent exemption from labelling

Wine, fining agents, milk products, casein, food allergy
First published in the EFSA Journal
6 October 2011
Adopted
15 September 2011
Type
Scientific Opinion
Abstract

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver a scientific opinion related to a notification from the International Organisation of Vine and Wine on casein/caseinate/milk products to be used in the manufacture of wine as clarification processing aids pursuant to Article 6, paragraph 11 of Directive 2000/13/EC – for permanent exemption from labelling. In earlier assessments, the Panel concluded that wines fined with casein/caseinate/milk products may trigger adverse reactions in susceptible individuals under the conditions of use stated by the applicants based on the limited information provided on the characterisation of the fining agents, on the limitations of the methods used to quantify casein and other milk allergens in wine, and on the clinical studies presented, which were inconclusive. This application refers to new analytical methods developed for the detection of milk allergens in the fining agent and the detection of casein in wine. There were no changes in the wine manufacturing process and no new clinical studies were provided. Taking into account the information provided on the characterisation of the fining agents regarding their content of milk proteins other than casein, the lack of standardisation of the wine manufacturing process, and that no new clinical data have been provided in the present application, the Panel concludes that wines fined with casein/caseinate/milk products may trigger adverse reactions in susceptible individuals under the proposed conditions of use.

Panel members at the time of adoption
Carlo Agostoni, Jean-Louis Bresson, Susan Fairweather-Tait, Albert Flynn, Ines Golly, Hannu Korhonen, Pagona Lagiou, Martinus Løvik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Monika Neuhäuser-Berthold, Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, Sean (J.J.) Strain, Stephan Strobel, Inge Tetens, Daniel Tomé, Hendrik van Loveren and Hans Verhagen
Panel on Dietetic Products, Nutrition and Allergies
Contact
nda [at] efsa.europa.eu
doi
10.2903/j.efsa.2011.2384
EFSA Journal 2011;9(10):2384 [13 pp.].
Question Number
On request from
European Commission